Moreover, expanding research to larger patient cohorts and diverse breast cancer subtypes could provide more comprehensive insight into the clinical relevance and generalizability of ASAP1 as a prognostic and therapeutic target. The gene discussed is ASAP1; the disease is breast carcinoma.